A Trial of the Fatty Acid Amide Hydrolase Inhibitor Palmitoylethanolamide in Bipolar Depression
Status:
RECRUITING
Trial end date:
2025-08-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to o evaluate the antidepressant efficacy of the PEA in Bipolar Depression and the association between antidepressant response with endogenous cannabinoids and cytokine levels
Phase:
PHASE2
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston